Short answer: the FDA regulatory pathway for medical devices depends on risk, intended use, and whether a similar device already exists.

The three main pathways are:

510(k) – for devices that are substantially equivalent to an existing legally marketed device

De Novo – for novel, low-to-moderate risk devices with no predicate

PMA (Premarket Approval) – for high-risk devices requiring clinical evidence

But definitions are not enough. What matters is decision logic.

The Decision Logic Behind FDA Pathways

The U.S. Food and Drug Administration does not choose pathways based on innovation level. They choose based on risk and existing regulatory history.

Here is how the decision actually works.

Step 1: What Is the Intended Use?

This is the starting point. Everything flows from intended use.

FDA first asks:

What condition does the device address?

Who will use it?

In what setting?

What claims are being made?

Intended use determines risk classification. And classification drives pathway.

Step 2: Is There a Predicate Device?

If a legally marketed device exists with:

The same intended use

Similar technological characteristics

No new safety concerns

Then a 510(k) pathway may be possible.

510(k) Logic:

If your device can show substantial equivalence to a predicate, you do not need to prove safety and effectiveness from scratch. You need to show it is not materially different in risk profile.

Typical profile:

Moderate-risk devices (Class II)

Bench and performance testing

Sometimes limited clinical data

If no appropriate predicate exists, 510(k) is not an option.

Step 3: Is the Device Low-to-Moderate Risk but Novel?

If there is no predicate, but the device presents low-to-moderate risk, the likely route is De Novo.

De Novo Logic:

If the device is new but risks can be mitigated through controls, FDA may create a new classification for it.

Typical profile:

First-of-a-kind technologies

Requires more data than 510(k)

Often includes clinical evidence

Longer review time

De Novo creates a new regulatory category. Future devices may then use it as a predicate.

Step 4: Is the Device High Risk?

If the device:

Sustains or supports life

Is implanted long-term

Presents significant potential harm if it fails

Then the pathway is likely PMA (Premarket Approval).

PMA Logic:

If risk is high, FDA requires valid scientific evidence, usually including well-controlled clinical trials.

Typical profile:

Class III devices

Extensive bench, animal, and clinical data

Most expensive and time-intensive pathway

Why Optimism Is Dangerous

Founders often choose pathways based on:

What they hope is easiest

What competitors did

What feels cheaper

FDA does not care about optimism.
They care about risk classification and evidence sufficiency.

Misclassifying your device early can result in:

Forced pathway changes

Repeated testing

12–24 months of delay

Millions in unexpected costs

The regulatory pathway is not a marketing decision. It is a risk decision.

Where Kandih Comes In

This is where Kandih Group supports founders and investors early.

Kandih helps teams:

Analyze intended use against FDA classification logic

Assess realistic predicate options

Identify hidden technological risk escalators

Evaluate whether De Novo is viable

Pressure-test whether PMA is unavoidable

Build pathway decisions based on risk, not optimism

Instead of guessing which pathway is easiest, teams make decisions grounded in regulatory reality.

That reduces surprises, protects capital, and improves investor confidence.

Bottom Line

The FDA regulatory pathway is not chosen.
It is determined by risk, intended use, and regulatory precedent.

Understanding the decision logic early prevents:

Costly pivots

Repeated testing

Investor hesitation

Strong regulatory strategy means choosing the right path the first time.

References

FDA – Classify Your Medical Device
https://www.fda.gov/medical-devices/overview-device-regulation/classify-your-medical-device

FDA – Premarket Notification 510(k)
https://www.fda.gov/medical-devices/premarket-submissions/premarket-notification-510k

FDA – De Novo Classification Process
https://www.fda.gov/medical-devices/premarket-submissions/de-novo-classification-request

FDA – Premarket Approval (PMA)
https://www.fda.gov/medical-devices/premarket-submissions/premarket-approval-pma